{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:06:34Z","timestamp":1773248794103,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.cyto.2015.02.019","type":"journal-article","created":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T07:30:40Z","timestamp":1425972640000},"page":"176-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients"],"prefix":"10.1016","volume":"73","author":[{"given":"Xinyuan","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiling","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaofeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2015.02.019_b0005","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/CIR.0b013e31828124ad","article-title":"Heart disease and stroke statistics\u20132013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2015.02.019_b0010","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham heart study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2015.02.019_b0015","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1001\/jama.292.20.2471","article-title":"Obesity and the risk of new-onset atrial fibrillation","volume":"292","author":"Wang","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.cyto.2015.02.019_b0020","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.amjmed.2005.01.031","article-title":"Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish diet, cancer, and health study","volume":"118","author":"Frost","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.cyto.2015.02.019_b0025","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jacc.2010.03.071","article-title":"Pericardial fat is independently associated with human atrial fibrillation","volume":"56","author":"Al Chekakie","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2015.02.019_b0030","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.jacc.2010.11.045","article-title":"Pericardial fat is associated with atrial fibrillation severity and ablation outcome","volume":"57","author":"Wong","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2015.02.019_b0035","first-page":"345","article-title":"Pericardial fat is associated with prevalent atrial fibrillation the Framingham heart study","volume":"3","author":"Thanassoulis","year":"2010","journal-title":"Circulation: Arrhythmia Electrophysiol"},{"key":"10.1016\/j.cyto.2015.02.019_b0040","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2015.02.019_b0045","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.cyto.2015.02.019_b0050","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2015.02.019_b0055","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.cyto.2015.02.019_b0060","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2337\/dc09-0684","article-title":"Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance","volume":"32","author":"Chavez","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cyto.2015.02.019_b0065","doi-asserted-by":"crossref","first-page":"e15534","DOI":"10.1371\/journal.pone.0015534","article-title":"Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile","volume":"5","author":"Lin","year":"2010","journal-title":"PloS one"},{"key":"10.1016\/j.cyto.2015.02.019_b0070","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/ATVBAHA.113.301599","article-title":"Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors","volume":"33","author":"Chow","year":"2013","journal-title":"Arterioscler Throm Vas Biol"},{"key":"10.1016\/j.cyto.2015.02.019_b0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/jhh.2012.52","article-title":"Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults","volume":"27","author":"Semba","year":"2012","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cyto.2015.02.019_b0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/cen.12134","article-title":"Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status","volume":"80","author":"Lee","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.cyto.2015.02.019_b0085","doi-asserted-by":"crossref","unstructured":"Fuster VRL, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JLLHJ, et al. American College of Cardiology\/, European AHATFoPG, European SoCCfPG, Society. HRAHR. ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257\u2013e354.","DOI":"10.1161\/CIRCULATIONAHA.106.177292"},{"key":"10.1016\/j.cyto.2015.02.019_b0090","article-title":"Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines","author":"Venteclef","year":"2013","journal-title":"Europ Heart J"},{"key":"10.1016\/j.cyto.2015.02.019_b0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00395-012-0293-1","article-title":"Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation","volume":"107","author":"Lin","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cyto.2015.02.019_b0100","doi-asserted-by":"crossref","first-page":"E351","DOI":"10.1210\/jc.2010-1326","article-title":"Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins","volume":"96","author":"Tyynismaa","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cyto.2015.02.019_b0105","doi-asserted-by":"crossref","first-page":"e24895","DOI":"10.1371\/journal.pone.0024895","article-title":"Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study","volume":"6","author":"Yan","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.cyto.2015.02.019_b0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jhep.2013.09.003","article-title":"Serum FGF21 increases with hepatic fat accumulation in pediatric onset intestinal failure","volume":"60","author":"Mutanen","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2015.02.019_b0115","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","article-title":"Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride","volume":"53","author":"Li","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.cyto.2015.02.019_b0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1475-2840-12-124","article-title":"Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease","volume":"12","author":"Shen","year":"2013","journal-title":"Cardiovas Diabetol"},{"key":"10.1016\/j.cyto.2015.02.019_b0125","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3019","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice","volume":"4","author":"Planavila","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.cyto.2015.02.019_b0130","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/srep02767","article-title":"Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue","volume":"3","author":"Liu","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.cyto.2015.02.019_b0135","doi-asserted-by":"crossref","first-page":"e87102","DOI":"10.1371\/journal.pone.0087102","article-title":"Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts","volume":"9","author":"Patel","year":"2014","journal-title":"PloS one"},{"key":"10.1016\/j.cyto.2015.02.019_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.931610","article-title":"Fibroblast growth factor 21: a novel metabolic regulator with potential therapeutic properties in obesity\/type 2 diabetes mellitus","volume":"58","author":"Dost\u00e1lov\u00e1","year":"2009","journal-title":"Physiol Res"},{"key":"10.1016\/j.cyto.2015.02.019_b0145","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1042\/CS20080372","article-title":"Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF)","volume":"116","author":"Pinto","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.cyto.2015.02.019_b0150","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2010.02.066","article-title":"Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population","volume":"56","author":"Marott","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cyto.2015.02.019_b0155","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jjcc.2013.10.008","article-title":"Increased level of resistin predicts development of atrial fibrillation","volume":"63","author":"\u00d6zcan","year":"2014","journal-title":"J Cardiol"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466615000782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T20:02:22Z","timestamp":1651435342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466615000782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1043466615000782"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2015.02.019","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2015.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}